Company and Product News: J. Sep. Sci. 18/2007
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 117 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1615-9306
No coin nor oath required. For personal study only.
โฆ Synopsis
Agilent Technologies to Acquire Velocity11
Agilent Technologies and Velocity11 have signed a definitive agreement for Agilent to acquire Velocity11. Menlo Park-based Velocity11 is specialised in automated liquid handling and laboratory robotics for the life science market. Financial details were not disclosed. The acquisition is expected to be final in 30 to 60 days, subject to certain closing conditions. The acquisition will enable Agilent to offer a more comprehensive suite of workflow solutions to its life science customers in the pharmaceutical, biotech, and academic research markets. Velo-city11 designs, manufactures and markets robotic solutions that range from standalone instrumentation to bench-top automation solutions and to large, multiarmed robotic systems. The company also develops software to control the robotics.
๐ SIMILAR VOLUMES
Dionex Corporation has established a new North American Sales and Service facility in Bannockburn, IL, north of Chicago. The site provides a centralised hub for
## Trace H 2 O in Argon GOW-MAC Instrument Company's newest process instrument, the Series 1400 Analyzer, measures trace amounts of moisture in argon. Two models cover different analytical ranges: Model 1400-A covers 0-2/0-20 ppm; Model 1400-B covers 0-20/0-200 ppm. Detection is based on spectral e
Thermo Fisher Scientific and MayLab Collaborate in Software Control for HPLC Thermo Fisher Scientific Inc. and MayLab Analytical Instruments have announced the release of new software control for MayLab's MistraSwitch multi column selector for the Mistral oven with Thermo's Scientific Surveyor Plus
Agilent Technologies Inc. has signed a definitive agreement with Stratagene Corp. of La Jolla, California to acquire the developer, manufacturer and marketer of specialised life science research and diagnostic products. Under the terms of the agreement, each share of Stratagene common stock will be